NURS 5432 Family Nurse Practitioner I Exam Study
Guide | NURS 5432 FNP I Review Questions and
Correct Answers | Latest Update 2026/2027 | Graded
A+.
What’s Inside:
• ✅ Full breakdown of all FNP I modules (Module 1–6 or more)
• ✅ Key topics: health promotion, chronic disease, pediatrics, adult care, screenings,
diagnostics
• ✅ Clear definitions, summaries, and key points
• ✅ Clinical pearls and test-ready material
• ✅ Aligned with UTA and other accredited FNP programs ✅ Covers content needed for
midterm and final exam success
• NURS 5432 students (University of Texas at Arlington or other
FNP programs)
• First-time exam takers or students needing a quick refresh
• FNP students preparing for clinical decision-making exams
Long-acting reversible contraception (LARC)
Effective birth control that lasts for years.
Tubal ligation
Surgical procedure for permanent birth control.
Menopause
12 months of amenorrhea in women over 40.
Perimenopause
Transition phase leading to menopause, lasts years.
DEXA scan
,Bone density test to diagnose osteoporosis.
Hormone Replacement Therapy (HRT)
Treatment to alleviate menopausal symptoms with hormones.
Breast cancer risk
Increased risk associated with long-term hormone therapy.
VTE
Venous thromboembolism, a risk with hormone therapy.
Short term use
Increases CVD, cancer, VTE risks long term.
Tailored therapy
Achieve lowest dose for shortest duration.
Menopause onset
Introduce therapy early for better risk/benefit.
Absolute contraindications
None for hormone replacement therapy.
Estrogen-dependent malignancies
Includes breast, ovarian, and uterine cancers.
Non-hormonal medications
Alternatives for managing menopause symptoms without hormones.
Gabapentin
Medication used for hot flashes in menopause.
Clonidine
Medication for mild hot flashes, less effective than SSRIs.
,Unexplained uterine bleeding
Requires evaluation before hormone therapy.
History of VTE/CVA
Higher estrogen doses cause hypercoagulability.
Coronary artery disease (CAD)
Avoid estrogen for cardio-protective benefits.
Estrogen and progesterone use
Depends on history of hysterectomy.
Fibroadenoma
Benign breast mass, smooth and
rubbery. Complex fibroadenoma
Includes cysts >3mm, sclerosing adenosis.
Fine needle aspiration biopsy
Used to rule out cancer in masses.
Fibrocystic breast disease
Common in premenopausal women, includes cysts.
Active liver disease
Higher estrogen doses may induce gallbladder disease.
Genitourinary Syndrome
Includes vulvar/vaginal atrophy symptoms.
Topical estrogen therapy
Reverses vaginal atrophy, enhances blood flow.
, Ospemifene
SERM for moderate to severe dyspareunia.
Nipple discharge
Typically benign, requires surgical referral.
Galactorrhea
Physiologic discharge; check TSH and prolactin.
Breast cancer risk factors
Includes familial link, dense tissue, obesity.
Mammogram screening recommendations
USPSTF: 50-74 biennial; ACS: 45 annually.
SERMs
Tamoxifen and Raloxifene for breast
cancer. Ovarian cancer risk factors
Includes family history and BRCA mutations.
Fundal height measurement
Palpable at umbilicus by 20 weeks.
Folic acid during pregnancy
0.4mg/day reduces neural tube defect risk.
Folic Acid
0.4mg/day reduces neural tube defect risk.
Tylenol
Safe pain relief medication during pregnancy.
Embryonic Period
Guide | NURS 5432 FNP I Review Questions and
Correct Answers | Latest Update 2026/2027 | Graded
A+.
What’s Inside:
• ✅ Full breakdown of all FNP I modules (Module 1–6 or more)
• ✅ Key topics: health promotion, chronic disease, pediatrics, adult care, screenings,
diagnostics
• ✅ Clear definitions, summaries, and key points
• ✅ Clinical pearls and test-ready material
• ✅ Aligned with UTA and other accredited FNP programs ✅ Covers content needed for
midterm and final exam success
• NURS 5432 students (University of Texas at Arlington or other
FNP programs)
• First-time exam takers or students needing a quick refresh
• FNP students preparing for clinical decision-making exams
Long-acting reversible contraception (LARC)
Effective birth control that lasts for years.
Tubal ligation
Surgical procedure for permanent birth control.
Menopause
12 months of amenorrhea in women over 40.
Perimenopause
Transition phase leading to menopause, lasts years.
DEXA scan
,Bone density test to diagnose osteoporosis.
Hormone Replacement Therapy (HRT)
Treatment to alleviate menopausal symptoms with hormones.
Breast cancer risk
Increased risk associated with long-term hormone therapy.
VTE
Venous thromboembolism, a risk with hormone therapy.
Short term use
Increases CVD, cancer, VTE risks long term.
Tailored therapy
Achieve lowest dose for shortest duration.
Menopause onset
Introduce therapy early for better risk/benefit.
Absolute contraindications
None for hormone replacement therapy.
Estrogen-dependent malignancies
Includes breast, ovarian, and uterine cancers.
Non-hormonal medications
Alternatives for managing menopause symptoms without hormones.
Gabapentin
Medication used for hot flashes in menopause.
Clonidine
Medication for mild hot flashes, less effective than SSRIs.
,Unexplained uterine bleeding
Requires evaluation before hormone therapy.
History of VTE/CVA
Higher estrogen doses cause hypercoagulability.
Coronary artery disease (CAD)
Avoid estrogen for cardio-protective benefits.
Estrogen and progesterone use
Depends on history of hysterectomy.
Fibroadenoma
Benign breast mass, smooth and
rubbery. Complex fibroadenoma
Includes cysts >3mm, sclerosing adenosis.
Fine needle aspiration biopsy
Used to rule out cancer in masses.
Fibrocystic breast disease
Common in premenopausal women, includes cysts.
Active liver disease
Higher estrogen doses may induce gallbladder disease.
Genitourinary Syndrome
Includes vulvar/vaginal atrophy symptoms.
Topical estrogen therapy
Reverses vaginal atrophy, enhances blood flow.
, Ospemifene
SERM for moderate to severe dyspareunia.
Nipple discharge
Typically benign, requires surgical referral.
Galactorrhea
Physiologic discharge; check TSH and prolactin.
Breast cancer risk factors
Includes familial link, dense tissue, obesity.
Mammogram screening recommendations
USPSTF: 50-74 biennial; ACS: 45 annually.
SERMs
Tamoxifen and Raloxifene for breast
cancer. Ovarian cancer risk factors
Includes family history and BRCA mutations.
Fundal height measurement
Palpable at umbilicus by 20 weeks.
Folic acid during pregnancy
0.4mg/day reduces neural tube defect risk.
Folic Acid
0.4mg/day reduces neural tube defect risk.
Tylenol
Safe pain relief medication during pregnancy.
Embryonic Period
